Heparin-Platelet Factor (PF) 4 Antibodies in Patients with Pseudothrombocytopenia: Coincidence or Association?

Thromb Haemost 2000; 84(06): 1123-1124
DOI: 10.1055/s-0037-1614185

Letter to the Editor

Schattauer GmbH

Authors

Ile Schwarzinger

¹From the Department of Laboratory Medicine, University of Vienna, Austria
Wolfgang Speiser

¹From the Department of Laboratory Medicine, University of Vienna, Austria
Norbert Lubenow

²Department of Immunology and Transfusion Medicine, Ernst-Moritz-Arndt University Greifswald, Austria
Andreas Greinacher

²Department of Immunology and Transfusion Medicine, Ernst-Moritz-Arndt University Greifswald, Austria
Simon Panzer

³Clinic for Blood Group Serology, University of Vienna, Austria

References
1 Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71: 247-51.
2 Warketin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol 1998; 35 (4 Suppl 5) 9-16.
3 Griffiths E, Dzik WH. Assays for heparin-induced thrombocytopenia. [Review]. Transfus Med 1997; 07: 1-11.
4 Berning H, Stilbo I. Pseudothrombocytopenia and the hematology laboratory. [Letter]. Lancet 1982; 02 8313 1469-70.
5 Panzer S, Auerbach A, Cechova E, Fischer G, Holensteiner A, Kittl E-M, Mayr WR, Putz M, Wagenbichler P, Walchshofer S. Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol 1995; 90: 655-60.